Alligator Bioscience AB (publ) financials at a glance

+ Portfolio

The revenue of Alligator Bioscience AB (publ) is reported as 0.0619 billion Kronor in the fiscal year 2023. The earnings were -0.55 Kronor per share in 2023, which was 37.5 higher than 2022. And about -0.19267 billion Kronor are reported as free cash flow in the financials of Alligator Bioscience AB (publ) 2023. No dividends were paid to the shareholders of the Alligator Bioscience AB (publ) stock OM:ATORX in the financial year 2023.

kr61.90M

Revenue

kr-0.55

Earnings Per Share

-,269.26%

Gross Margin %

kr-,231.00M

Free Cash Flow

Revenue

61.90

Earnings Per Share

-0.55

Gross Margin %

-,269.26

Free Cash Flow

-,231.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	kr61.90M	kr37.14M	kr15.13M	kr6.67M	kr5.40M	kr28.51M	kr57.77M	kr59.35M	kr0.00M
GM %	Gross Margin %	-,212.20%	-,269.26%	0.00%	0.00%	0.00%	0.00%	0.00%	-26.72%	1.25%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-,108.98%	-58.90%	0.00%
EPS	Earnings Per Share	kr-0.66	kr-0.55	kr-0.88	kr-0.64	kr-2.01	kr-2.94	kr-2.10	kr-0.89	kr-0.80	kr3.70
Div.	Dividends	N/A	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0
Sha.	Shares	N/AM	657.95M	220.58M	220.58M	85.67M	71.39M	71.39M	71.39M	70.11M	59.01M
OCF	Operating Cash Flow	N/A	kr-,189.29M	kr-,172.61M	kr-,127.03M	kr-,141.35M	kr-,178.96M	kr-,104.12M	kr-99.63M	kr-37.61M	kr0.00M
FCF	Free Cash Flow	N/A	kr-,231.00M	kr-,173.05M	kr-,127.08M	kr-,141.45M	kr-,181.15M	kr-,111.78M	kr-,113.83M	kr-40.99M	kr0.00M
FCFS	Free Cash Flow Per Share	kr-0.52	kr-0.43	kr-0.78	kr-0.58	kr-1.98	kr-2.54	kr-1.57	kr-1.60	kr-0.69	kr0.00

Alligator Bioscience AB (publ) financials at a glance

Financials

Discover